Clinical significance of serum glutathione reductase in various clinical conditions, especially in liver diseases.
Serum glutathione reductase activity was measured in various conditions including acute hepatitis, chronic hepatitis, liver cirrhosis, malignant neoplastic diseases, and obstructive jaundice. A statistically significant elevation of the enzyme activity was found in all of these clinical conditions above normal value, especially in patients with acute hepatitis, some liver cancer, and malignant biliary obstruction. Comparison with other liver function tests showed the existence of statistically significant correlations of serum glutathione reductase with SGOT, SGPT and alkaline phosphatase in acute hepatitis, and with alkaline phosphatase in cirrhosis. In parenchymatous liver disease, serial determination was found to be important. High values in obstructive jaundice suggest the malignant obstruction.
D000328:Adult; D002769:Cholelithiasis / Q000097:blood / Q000201:enzymology; D002779:Cholestasis / Q000097:blood / Q000201:enzymology; D005260:Female; D005980:Glutathione Reductase / Q000097:blood*; D006505:Hepatitis / Q000097:blood / Q000201:enzymology; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000201:enzymology; D008107:Liver Diseases / Q000097:blood / Q000201:enzymology*; D008113:Liver Neoplasms / Q000097:blood / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013274:Stomach Neoplasms / Q000097:blood / Q000201:enzymology
D005980:Glutathione Reductase